Skip to main content
Erschienen in: Gastric Cancer 2/2011

01.06.2011 | Original Article

The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification

verfasst von: Sumin Chae, Anbok Lee, Joo-Ho Lee

Erschienen in: Gastric Cancer | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The most important prognostic factor after curative surgery for gastric carcinoma is the presence of lymph node metastases. According to the 7th edition of the UICC TNM staging system for gastric cancer, N classification was categorized as N0 (no regional lymph node metastasis), N1 (1–2 regional lymph node metastases), N2 (3–6 regional lymph node metastases), and N3 (7 or more regional lymph node metastases). The purpose of this study was to evaluate the rationality of the new UICC/AJCC N classification in comparison with the 6th UICC classification.

Methods

From August 2002 to July 2006, 295 patients with gastric cancer underwent curative resection with D2 lymph node dissection by a single surgeon. We analyzed retrospectively the significant prognostic factors and identified the suitability of the 7th UICC N staging system.

Results

According to the 7th UICC N classification, the 5-year cumulative survival rates (5-YSR) of N0, N1, N2, N3a, and N3b were 89.7, 73.6, 54.9, 23.1, and 5.4%, respectively (P < 0.0001). Using univariate analysis, the N classification of the 7th and 6th UICC/AJCC TNM staging system, T classification of the 7th UICC TNM staging system, size and location of tumor, and histology were associated with the overall survival of gastric cancer after curative surgery. However, Cox regression multivariate analysis showed the 7th UICC N classification was an independent prognostic factor instead of the 6th UICC N classification (P < 0.0001).

Conclusion

The 7th UICC classification for lymph node metastasis is thought to be a more reliable prognostic factor for gastric cancer than the 6th classification.
Literatur
2.
Zurück zum Zitat Sobin LH. TNM: principles, history, and relation to other prognostic factors. Cancer. 2001;91:1589–92.CrossRefPubMed Sobin LH. TNM: principles, history, and relation to other prognostic factors. Cancer. 2001;91:1589–92.CrossRefPubMed
3.
Zurück zum Zitat Manfe AZ, Segalina P, Maffei Faccioli A. Prognostic factors in gastric cancer. Our experience and review of the literature. Minerva Chir. 2000;55:299–305.PubMed Manfe AZ, Segalina P, Maffei Faccioli A. Prognostic factors in gastric cancer. Our experience and review of the literature. Minerva Chir. 2000;55:299–305.PubMed
4.
Zurück zum Zitat Del Rio P, Dell’Abate P, Soliani P, Arcuri MF, Tacci S, Ziegler S, et al. Old and New TNM in carcinoma of gastric antrum: analysis of our personal experience. J Gastrointest Surg. 2003;7:912–6.CrossRefPubMed Del Rio P, Dell’Abate P, Soliani P, Arcuri MF, Tacci S, Ziegler S, et al. Old and New TNM in carcinoma of gastric antrum: analysis of our personal experience. J Gastrointest Surg. 2003;7:912–6.CrossRefPubMed
5.
Zurück zum Zitat Maruyama K, Sasako M, Kinoshita T. Prognostic factors of gastric cancer patients and new TNM classification [abstract]. Gut. 1999;45(suppl 5):66A. Maruyama K, Sasako M, Kinoshita T. Prognostic factors of gastric cancer patients and new TNM classification [abstract]. Gut. 1999;45(suppl 5):66A.
6.
Zurück zum Zitat D’Ugo D, Pacelli F, Persiani R, Pende V, Ianni A, Papa V, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. World J Surg. 2002;26:672–7.CrossRefPubMed D’Ugo D, Pacelli F, Persiani R, Pende V, Ianni A, Papa V, et al. Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. World J Surg. 2002;26:672–7.CrossRefPubMed
7.
Zurück zum Zitat Kim JP, Kim YW, Yang HK, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg. 1994;18:872–7.CrossRefPubMed Kim JP, Kim YW, Yang HK, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg. 1994;18:872–7.CrossRefPubMed
8.
Zurück zum Zitat Siewert JR, Bottecher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449–61.CrossRefPubMedPubMedCentral Siewert JR, Bottecher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449–61.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Deng JY, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol. 2010;17:1259–66.CrossRefPubMed Deng JY, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol. 2010;17:1259–66.CrossRefPubMed
10.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1998; 1: 10–24CrossRefPubMed Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1998; 1: 10–24CrossRefPubMed
11.
Zurück zum Zitat Hermanek P, Sobin L.H (eds) TNM Classification of Malignant Tumors (UICC). 4th edn. Berlin: Springer; 1987. pp. 43–46 Hermanek P, Sobin L.H (eds) TNM Classification of Malignant Tumors (UICC). 4th edn. Berlin: Springer; 1987. pp. 43–46
12.
Zurück zum Zitat Sobin LH, Wittekind CH. TNM classification of malignant tumors (UICC). 5th ed. New York: Wiley; 1997. p. 59–62. Sobin LH, Wittekind CH. TNM classification of malignant tumors (UICC). 5th ed. New York: Wiley; 1997. p. 59–62.
13.
Zurück zum Zitat Sobin LH, Wittekind C, Gospodarowicz M (eds) TNM classification of malignant tumors (UICC). 7th edn. New York: Wiley-Blackwell; 2009. pp. 73–77 Sobin LH, Wittekind C, Gospodarowicz M (eds) TNM classification of malignant tumors (UICC). 7th edn. New York: Wiley-Blackwell; 2009. pp. 73–77
14.
15.
Zurück zum Zitat Yamamura Y, Nakajima T, Ohta K, Nashimoto A, Arai K, Hiratsuka M, et al. Determining prognostic factors for gastric cancer using the regression tree method. Gastric Cancer. 2002;5:201–7.CrossRefPubMed Yamamura Y, Nakajima T, Ohta K, Nashimoto A, Arai K, Hiratsuka M, et al. Determining prognostic factors for gastric cancer using the regression tree method. Gastric Cancer. 2002;5:201–7.CrossRefPubMed
16.
Zurück zum Zitat Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35.PubMedPubMedCentral Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35.PubMedPubMedCentral
17.
Zurück zum Zitat Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000;85:286–90.PubMed Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000;85:286–90.PubMed
18.
Zurück zum Zitat Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer. 1998;1:125–33.CrossRefPubMed Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer. 1998;1:125–33.CrossRefPubMed
19.
Zurück zum Zitat Omejc M, Juvan R, Jelenc F, Repse S. Lymph node metastases in gastric cancer: Correlation between new and old UICC TNM classification. Int Surg. 2001;86:14–9.PubMed Omejc M, Juvan R, Jelenc F, Repse S. Lymph node metastases in gastric cancer: Correlation between new and old UICC TNM classification. Int Surg. 2001;86:14–9.PubMed
20.
Zurück zum Zitat Hermanek P. The superiority of the new international Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer. 2000;88:1763–5.CrossRefPubMed Hermanek P. The superiority of the new international Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer. 2000;88:1763–5.CrossRefPubMed
21.
Zurück zum Zitat Ichikura T, Tomimatsu S, Uefuji K, Kimura M, Uchida T, Morita D, et al. Evaluation of the new American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer. 1999;86:553–8.CrossRefPubMed Ichikura T, Tomimatsu S, Uefuji K, Kimura M, Uchida T, Morita D, et al. Evaluation of the new American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer. 1999;86:553–8.CrossRefPubMed
22.
Zurück zum Zitat Celen O, Yildirim E, Gulben K, Berberoglu U. Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system. Eur J Surg Suppl. 2003;588:33–9. Celen O, Yildirim E, Gulben K, Berberoglu U. Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system. Eur J Surg Suppl. 2003;588:33–9.
23.
Zurück zum Zitat Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27–34.CrossRefPubMed Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27–34.CrossRefPubMed
24.
Zurück zum Zitat Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D’Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol. 2007;34:519–24.CrossRefPubMed Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D’Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol. 2007;34:519–24.CrossRefPubMed
25.
Zurück zum Zitat Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol. 2008;98:343–8.CrossRefPubMed Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol. 2008;98:343–8.CrossRefPubMed
26.
Zurück zum Zitat Huang B, Zheng X, Wang Z, Wang M, Dong Y, Zhao B, et al. Prognostic significance of the number of metastatic lymph nodes: is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol. 2009;16:61–7.CrossRefPubMed Huang B, Zheng X, Wang Z, Wang M, Dong Y, Zhao B, et al. Prognostic significance of the number of metastatic lymph nodes: is UICC/TNM node classification perfectly suitable for early gastric cancer? Ann Surg Oncol. 2009;16:61–7.CrossRefPubMed
27.
Zurück zum Zitat Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer. 2000;88:1796–800.CrossRefPubMed Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer. 2000;88:1796–800.CrossRefPubMed
28.
Zurück zum Zitat Yang H, Ahn H, Yoon H, Kong S, Cho J, Park D, et al. Application of new TNM staging system for gastric cancer and prognostic significance of the number of metastatic lymph nodes. abstract 8th IGCC 2009, S51, pp. 29 Yang H, Ahn H, Yoon H, Kong S, Cho J, Park D, et al. Application of new TNM staging system for gastric cancer and prognostic significance of the number of metastatic lymph nodes. abstract 8th IGCC 2009, S51, pp. 29
29.
Zurück zum Zitat Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001;84(1):64–71.CrossRefPubMedPubMedCentral Klein Kranenbarg E, Hermans J, van Krieken JH, van de Velde CJ. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001;84(1):64–71.CrossRefPubMedPubMedCentral
Metadaten
Titel
The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification
verfasst von
Sumin Chae
Anbok Lee
Joo-Ho Lee
Publikationsdatum
01.06.2011
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 2/2011
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0024-6

Weitere Artikel der Ausgabe 2/2011

Gastric Cancer 2/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.